Trial Profile
A phase I study investigating the effect of vinorelbine in advanced non-small cell lung cancer patients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Dec 2015
Price :
$35
*
At a glance
- Drugs Vinorelbine (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Pharmacokinetics
- 06 Dec 2015 New trial record